Anne L. van de Ven
Cited by
Cited by
Synthetic nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like functions
A Parodi, N Quattrocchi, AL van de Ven, C Chiappini, M Evangelopoulos, ...
Nature nanotechnology 8 (1), 61-68, 2013
Enabling individualized therapy through nanotechnology
JH Sakamoto, AL van de Ven, B Godin, E Blanco, RE Serda, A Grattoni, ...
Pharmacological Research 62 (2), 57-89, 2010
Rapid tumoritropic accumulation of systemically injected plateloid particles and their biodistribution
AL van de Ven, P Kim, OH Haley, JR Fakhoury, G Adriani, J Schmulen, ...
Journal of Controlled Release 158 (1), 148-155, 2012
Integrated intravital microscopy and mathematical modeling to optimize nanotherapeutics delivery to tumors
AL van de Ven, M Wu, J Lowengrub, SR McDougall, MAJ Chaplain, ...
AIP advances 2 (1), 011208, 2012
Logic‐Embedded Vectors for Intracellular Partitioning, Endosomal Escape, and Exocytosis of Nanoparticles
RE Serda, A Mack, AL van de Ven, S Ferrati, K Dunner, B Godin, ...
Small 6 (23), 2691-2700, 2010
Superparamagnetic iron oxide-encapsulating polymersome nanocarriers for biofilm eradication
BM Geilich, I Gelfat, S Sridhar, AL van de Ven, TJ Webster
Biomaterials 119, 78-85, 2017
Computational Modeling of 3D Tumor Growth and Angiogenesis for Chemotherapy Evaluation
L Tang, AL van de Ven, D Guo, V Andasari, V Cristini, KC Li, X Zhou
PloS one 9 (1), e83962, 2014
Silver nanoparticle-embedded polymersome nanocarriers for the treatment of antibiotic-resistant infections
BM Geilich, AL van de Ven, GL Singleton, LJ Sepúlveda, S Sridhar, ...
Nanoscale 7 (8), 3511-3519, 2015
Silicon micro‐and nanofabrication for medicine
D Fine, A Grattoni, R Goodall, SS Bansal, C Chiappini, S Hosali, ...
Advanced healthcare materials 2 (5), 632-666, 2013
Sustained Zero‐Order Release of Intact Ultra‐Stable Drug‐Loaded Liposomes from an Implantable Nanochannel Delivery System
C Celia, S Ferrati, S Bansal, AL van de Ven, B Ruozi, E Zabre, S Hosali, ...
Advanced healthcare materials 3 (2), 230-238, 2014
Serum biomarkers for personalization of nanotherapeutics-based therapy in different tumor and organ microenvironments
K Yokoi, T Tanei, B Godin, AL van de Ven, M Hanibuchi, A Matsunoki, ...
Cancer letters 345 (1), 48-55, 2014
Cell source determines the immunological impact of biomimetic nanoparticles
M Evangelopoulos, A Parodi, JO Martinez, IK Yazdi, A Cevenini, ...
Biomaterials 82, 168-177, 2016
Cell source determines the immunological impact of biomimetic nanoparticles
A Parodi, C Boada, N Taghipour, M Evangelopoulos, BS Brown, ...
Biomaterials 82, 2015
Modeling of nanotherapeutics delivery based on tumor perfusion
AL van de Ven, B Abdollahi, CJ Martinez, LA Burey, MD Landis, ...
New Journal of Physics 15 (5), 055004, 2013
Red blood cell tracking using optical flow methods
D Guo, AL van de Ven, X Zhou
Biomedical and Health Informatics, IEEE Journal of 18 (3), 991-998, 2014
Delivery of optical contrast agents using Triton-X100, part 1: reversible permeabilization of live cells for intracellular labeling
AL Van de Ven, K Adler-Storthz, RR Richards-Kortum
Journal of biomedical optics 14 (2), 021012, 2009
Nanoformulation of Olaparib amplifies PARP inhibition and sensitizes PTEN/TP53-deficient prostate cancer to radiation
AL van de Ven, S Tangutoori, P Baldwin, J Qiao, C Gharagouzloo, ...
Molecular cancer therapeutics 16 (7), 1279-1289, 2017
Efficient mucosal delivery of optical contrast agents using imidazole-modified chitosan
B Ghosn, AL van de Ven, JO Tam, AM Gillenwater, KV Sokolov, ...
Journal of biomedical optics 15 (1), 015003, 2010
Real-time intravital microscopy of individual nanoparticle dynamics in liver and tumors of live mice
AL van de Ven, P Kim, M Ferrari, SH Yun
Protocol exchange 2013, 2013
Proteomic analysis of serum opsonins impacting biodistribution and cellular association of porous silicon microparticles.
RE Serda, E Blanco, A Mack, SJ Stafford, S Amra, Q Li, A van de Ven, ...
Molecular imaging 10 (1), 43, 2011
The system can't perform the operation now. Try again later.
Articles 1–20